Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Dasatinib in Relapsed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00438854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00751296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01373229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT06637501. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia Wi
ClinicalTrials.gov study NCT03190330. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
ClinicalTrials.gov study NCT00546377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00718549. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01609023. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01600053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00014560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
ClinicalTrials.gov study NCT02649387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
ClinicalTrials.gov study NCT02309515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CFAR Study in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00525603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00625729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02042911. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01500083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00918723. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02071225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02533401. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
ClinicalTrials.gov study NCT02013817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.